Varex Imaging Corporation (VREX) is a Medical - Devices company in the Healthcare sector, currently trading at $11.74. It has a SharesGrow Score of 44/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of VREX = $24.66 (+110.1% from the current price, the stock appears undervalued). Analyst consensus target is VREX = $15 (+23.5% upside).
Valuation: VREX trades at a trailing Price-to-Earnings (P/E) of -6.7 (S&P 500 average ~25).
Financials: revenue is $845M, -0.4%/yr average growth. Net income is $70M (loss), growing at -62.4%/yr. Net profit margin is -8.3% (negative). Gross margin is 34.4% (+1.4 pp trend).
Balance sheet: total debt is $402M against $473M equity (Debt-to-Equity (D/E) ratio 0.85, moderate). Current ratio is 3.43 (strong liquidity). Debt-to-assets is 36.3%. Total assets: $1.1B.
Analyst outlook: 4 / 6 analysts rate VREX as buy (67%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 75/100 (Pass), Growth 15/100 (Fail), Past 50/100 (Partial), Health 50/100 (Partial), Moat 40/100 (Fail), Future 67/100 (Pass), Income 10/100 (Fail).
